Trial NCT01267266

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2011-02563
Secondary IDs: 10-436-B 8446 CDR0000691725 N01CM00071 N01CM00099 NCI-2011-02563 P30CA014599 U01CA062491

Last trial update was posted on 2015-04-01

MeSH Interventions

Hydrocortisone Saracatinib

MeSH Conditions

Prostatic Neoplasms

Other Conditions

Hormone-resistant Prostate Cancer Recurrent Prostate Cancer Stage IV Prostate Cancer

Stopping Reasons

Per protocol, study was terminated due to low rate of randomized patients.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID